From Google Scholar+: Dissertations, Theses, Selected Journal Articles

Epidemiology of Invasive Pneumococcal Disease among High-Risk Adults since Introduction of Pneumococcal Conjugate Vaccine for Children
RD Muhammad, R Oza-Frank, E Zell, R Link-Gelles… – Clinical Infectious Diseases, 2012
Background. Certain chronic diseases increase risk for invasive pneumococcal disease (IPD) and are indications for receipt of 23-valent pneumococcal polysaccharide vaccine (PPV23). Since the pediatric introduction of 7-valent pneumococcal conjugate vaccine ( …

Accelerating the development of a therapeutic vaccine for human Chagas disease: rationale and prospects
E Dumonteil, ME Bottazzi, B Zhan, MJ Heffernan… – Expert Review of Vaccines, 2012
Chagas disease is a leading cause of heart disease affecting approximately 10 million people in Latin America and elsewhere worldwide. The two major drugs available for the treatment of Chagas disease have limited efficacy in Trypanosoma cruzi-infected adults …

Science denial: a guide for scientists
J Rosenau – Trends in Microbiology, 2012
… You do not expect to see Draco Malfoy carrying a Hermione Granger poster, let alone one in which she touts the whooping cough vaccine. Yet at the … scientific consensus. The vaccine drive at Dragon*Con fits this model beautifully. The …

Interview: Future of immunotherapy for colorectal cancer
J Marshall – Colorectal Cancer, 2012
… maintaining his regular clinical practice. His own research focuses on the development of a novel vaccine for the treatment of advanced colon cancer. Q What led you to focus your research on immunotherapy in colorectal cancer? …